Roger Smith
74Patents
16h-index
166Co-inventors
87Inventor score
Filing activity: Dec 7, 1987 → Jul 6, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5055451A | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | Emerging Cross-Sectional Technologies | 65 | Expired |
| US8101773B2 | Hydroxy methyl phenyl pyrazolyl urea compounds useful in the treatment of cancer | Human Necessities | 57 | Active |
| US6187799A | Inhibition of raf kinase activity using aryl ureas | Chemistry; Metallurgy | 53 | Expired |
| US7329670B1 | Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas | Chemistry; Metallurgy | 49 | Expired |
| US7235576B1 | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | Chemistry; Metallurgy | 47 | Expired |
| US7838524B2 | Substituted pyrazolyl urea derivatives useful in the treatment of cancer | Chemistry; Metallurgy | 46 | Active |
| US7351834B1 | ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | Chemistry; Metallurgy | 40 | Expired |
| US6344476B1 | Inhibition of p38 kinase activity by aryl ureas | Emerging Cross-Sectional Technologies | 35 | Expired |
| US5158936A | Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors | Emerging Cross-Sectional Technologies | 34 | Expired |
| US7625915B2 | Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas | Chemistry; Metallurgy | 32 | Active |
| US7897623B2 | ω-carboxyl aryl substituted diphenyl ureas as p38 kinase inhibitors | Emerging Cross-Sectional Technologies | 26 | Active |
| US7528255B2 | Hydroxy, ω-carboxyaryl substituted diphenyl ureas and dirivatives thereof as raf kinase inhibitors | Chemistry; Metallurgy | 25 | Expired |
| US8207166B2 | Substituted pyrazolyl urea derivatives useful in the treatment of cancer | Chemistry; Metallurgy | 22 | Active |
| US6395282B1 | Immunogenic conjugates of Gram-negative bacterial autoinducer molecules | Emerging Cross-Sectional Technologies | 22 | Expired |
| US8124630B2 | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | Chemistry; Metallurgy | 19 | Expired |
| US7517880B2 | Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas | Emerging Cross-Sectional Technologies | 18 | Expired |
| US7371763B2 | Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas | Human Necessities | 14 | Expired |
| US6660752B2 | 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists | Chemistry; Metallurgy | 12 | Expired |
| US7928239B2 | Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas | Chemistry; Metallurgy | 11 | Expired |
| US6960601B2 | Preparation and use of imidazole derivatives for treatment of obesity | Chemistry; Metallurgy | 10 | Expired |
| US7928227B2 | 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders | Chemistry; Metallurgy | 9 | Expired |
| US8841330B2 | Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors | Chemistry; Metallurgy | 8 | Active |
| US7091228B2 | Preparation and use of aryl alkyl acid derivatives for the treatment of obesity | Chemistry; Metallurgy | 8 | Expired |
| US8076488B2 | Bicyclic urea derivatives useful in the treatment of cancer and other disorders | Chemistry; Metallurgy | 8 | Expired |
| US8440662B2 | Substituted quinazoline and pyrido-pyrimidine derivatives | Chemistry; Metallurgy | 8 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.